Eli Lilly hopes the device can be more convenient for Zepbound users and lead to more people taking the drug.
Eli Lilly, the drugmaker behind weight-loss treatments Mounjaro and Zepbound, has rapidly overtaken former market leader Novo ...
Ben took his drugs ‘on the rocks’. Instead of diluting the methamphetamine with water, he’d draw blood into a syringe, ...
The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...
The new KwikPen holds four weekly doses.
"Stroking her soft face and trying to keep the tears back, I knew our lives would never be the same." ...
The shift emerged rapidly. In 2021, the country’s two main sexual health hubs, in Suva and Lautoka, did not report a single HIV case transmitted through drug use. Three years later, people injecting ...
Why argenx (ENXTBR:ARGX) is drawing investor attention now argenx (ENXTBR:ARGX) has moved higher in the past month and remains positive over the past year, even with a negative return over the past 3 ...
NINGBO, ZHEJIANG, CHINA, February 3, 2026 /EINPresswire.com/ -- As the global healthcare industry continues to evolve, ...